![[SIGN thistle header]](images/page-header-template.jpg)
sign 131 management of schizophrenia
Schizophrenia is a relatively common mental disorder, which typically manifests in young people in their twenties and is usually a lifelong condition.
About half of people with schizophrenia do not adhere to pharmacological treatment in the short term and even fewer adhere in the longer term. Working with people with schizophrenia to find the most appropriate medication is a challenge for healthcare professions.
This guideline provides evidence based recommendations for the care and treatment of adults with schizophrenia and will be of particular interest to mental health specialists working with people diagnosed with schizophrenia including psychiatrists, psychologists and specialist mental health nurses and occupational therapists providing health and social services.
It will also be of relevance to general practitioners and pharmacists.
 |
 |
 |
 |
|||
 |
|||
 |
|||
 |
|||
 |
 |
 |
 |
New on the site
10 May 2013
Management of Epithelial Ovarian Cancer peer review draft published.
15 April 2013
Mood disorders during pregnancy and after the birth of your baby patient booklet. Chinese, Polish and Urdu translations published.
27 March 2013
Long term follow up of
survivors of childhood cancer published.
Management of schizophrenia published.
14 March 2013
Brain injury rehabilitation in adults published.
14 March 2013
Policy Statement on the Grading of Recommendations in SIGN Guidelines added.
5 March 2013
SIGN App updated, CHD Guidelines added
![[RSS news feed]](images/rss.gif){kind=small}
RSS news feed
Scottish Intercollegiate Guidelines Network,
Healthcare Improvement Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh EH12 9EB
Tel. 0131 623 4720
Web contact duncan.service@nhs.net
Last modified
10/05/13
© SIGN 2001-2013